1. Home
  2. LITB vs ENTX Comparison

LITB vs ENTX Comparison

Compare LITB & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightInTheBox Holding Co. Ltd.

LITB

LightInTheBox Holding Co. Ltd.

BUY

Current Price

$2.26

Market Cap

47.2M

ML Signal

BUY

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.12

Market Cap

50.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LITB
ENTX
Founded
2007
2010
Country
Singapore
Israel
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.2M
50.9M
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
LITB
ENTX
Price
$2.26
$1.12
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
11.8K
177.4K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.25
Revenue
N/A
$42,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.96
$4.60
Revenue Growth
N/A
N/A
52 Week Low
$1.06
$0.91
52 Week High
$4.17
$3.22

Technical Indicators

Market Signals
Indicator
LITB
ENTX
Relative Strength Index (RSI) 45.07 45.46
Support Level $1.84 $0.96
Resistance Level $2.25 $1.61
Average True Range (ATR) 0.22 0.15
MACD 0.01 0.01
Stochastic Oscillator 57.58 45.83

Price Performance

Historical Comparison
LITB
ENTX

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company operates in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of provision of logistic services to companies and to individual customers. It derives maximum revenue from Product Sales. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: